Filing Details

Accession Number:
0001209191-17-026564
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-11 16:14:55
Reporting Period:
2017-04-10
Filing Date:
2017-04-11
Accepted Time:
2017-04-11 16:14:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202335 W David Gryska 1801 Augustine Cut-Off
Wilmington DE 19803
Executive Vice President, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-04-10 1,739 $67.06 20,754 No 4 M Direct
Common Stock Acquisiton 2017-04-10 39,789 $67.06 60,543 No 4 M Direct
Common Stock Disposition 2017-04-10 1,739 $138.00 58,804 No 4 S Direct
Common Stock Disposition 2017-04-10 39,789 $138.00 19,015 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2017-04-10 1,739 $0.00 1,739 $67.06
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-04-10 39,789 $0.00 39,789 $67.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,734 2021-10-30 No 4 M Direct
11,114 2021-10-30 No 4 M Direct
Footnotes
  1. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
  2. Represents weighted average sale price. Actual sale prices ranged from $136.10 - $140.71.
  3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  4. Beginning October 31, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.